Advertisement

Rheumatology International

, Volume 10, Issue 4, pp 159–163 | Cite as

Complement-mediated inhibition of immune precipitation in rheumatoid vasculitis

  • M. M. O'Sullivan
  • N. Amos
  • A. Bedwell
  • B. D. Williams
Article

Summary

Complement-mediated inhibition of immune precipitation (CMIP) was measured in patients with rheumatoid arthritis (RA), rheumatoid vasculitis (RA VASC), patients with skin vasculitis not associated with a systemic connective tissue disease and normal healthy controls. CMIP was impaired in 100% (14/14) of the RA vasculitic patients, 60% (12/20) of the RA patients and 22% (2/9) of the dermovasculitic patients. The degree of impairment of CMIP was significantly greater in the RA vasculitic patients compared to the non-vasculitic patients. This difference was due to the significantly lower complement levels and the presence of higher concentrations of an inhibitor of CMIP in the RA vasculitic sera. The levels of this inhibitory activity correlated significantly with IgM rheumatoid factor concentration. Serial studies in three patients with RA vasculitis treated with corticosteroids and immunosuppressive drugs showed significant clinical improvement in two patients, which was associated with improvement in CMIP, reduction in circulating immune complex levels and reduction in IgM rheumatoid factor concentrations.

Key words

Solubilization of immune complexes IgM rheumatoid factor Inhibitors of complement 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Schifferli JA, Ng YC, Peters DK (1986) The role of complement and its receptor in the elimination of immune complexes. N Engl J Med 315: 488–495PubMedGoogle Scholar
  2. 2.
    Naama JK, Mitchell WS, Whaley K (1983) Inhibition of complement mediated solubilisation of antigen antibody complexes by sera from patients with rheumatoid arthritis. Clin Exp Immunol 54: 429–438PubMedGoogle Scholar
  3. 3.
    Mitchell WS, Naama JK, Veitch J, Whaley K (1984) IgM-RF prevents complement mediated inhibition of immune precipitation. Immunology 52: 445–448PubMedGoogle Scholar
  4. 4.
    Balestrieri G, Tincani A, Migliorini P, Ferre C, Cattaneo R and Bombardieri S (1984) Inhibitory effect of IgM rheumatoid factor on immune complex solubilization capacity and inhibition of immune precipitation. Arthritis Rheum 27: 1130–1136PubMedGoogle Scholar
  5. 5.
    O'Sullivan MM, Amos N, Williams BD (1988) Complement mediated inhibition of immune precipitation in rheumatoid arthritis: Studies on the interaction of heat aggregated IgG with IgM rheumatoid factor. Ann Rheum Dis 47: 675–680PubMedGoogle Scholar
  6. 6.
    Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315–324PubMedGoogle Scholar
  7. 7.
    Schifferli JA, Bartolotti SR, Peters DK (1980) Inhibition of immune precipitation by complement. Clin Exp Immunol 42: 387–394PubMedGoogle Scholar
  8. 8.
    Laurell CB (1972) Electroimmunoassay. Scand J Clin Lab Invest [Suppl 124] 29: 21–37Google Scholar
  9. 9.
    Barratt J, Naish P (1979) A simple radiolabelled rheumatoid factor binding assay for the measurement of circulating immune complexes. J Immunol Methods 25: 137–147CrossRefPubMedGoogle Scholar
  10. 10.
    Faith A, Pontesili O, Unger A, Panayi GS, Johns P (1982) ELISA assay for IgM and IgG Rheumatoid Factors. J Immunol Methods 55: 169–177CrossRefPubMedGoogle Scholar
  11. 11.
    Waxmann FJ, Hebert LA, Cornacoff JB, Van Aman ME, Smead WL, Kraut EM, Birmingham DJ, Taguiam JM (1984) Complement depletion accelerates the clearance of immune complexes from the circulation of primates. J Clin Invest 74: 1329–1340Google Scholar
  12. 12.
    Cornacoff JB, Hebert LA, Smead WL, Van Aman ME, Birmingham DJ, Waxmann FJ (1983) Primate erythrocyte-immune complex-clearing mechanism. J Clin Invest 21: 236–247Google Scholar
  13. 13.
    Waxman FJ, Hebert LA, Cosio FG, Smead WL, Van Aman ME, Taguiam JM, Birmingham DJ (1986) Differential binding of immunoglobulin A and immunoglobulin G1 immune complexes to primate erythrocytes in vivo: immunoglobulin A immune complexes bind less well to erythrocytes and are preferentially deposited in glomeruli. J Clin Invest 77: 82–89PubMedGoogle Scholar
  14. 14.
    Schifferli JA, Ng YC, Estreicher J, Walport MJ (1988) The clearance of tetanus toxoid/anti-tetanus immune complexes from the circulation of humans: complement and erythrocyte CR1 dependent mechanisms. J Immunol 140: 899–904PubMedGoogle Scholar
  15. 15.
    Schifferli JA, Ng YC, Paccaud JP, Walport MJ (1989) The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans. Clin Exp Immunol 75: 329–335PubMedGoogle Scholar
  16. 16.
    Conn DL, McDuffie FC, Duke PJ (1972) Immunopathologic study of sural nerves in rheumatoid arthritis. Arthritis Rheum 15: 135–143PubMedGoogle Scholar
  17. 17.
    Franco AE, Schur PH (1981) Hypocomplementaemia in rheumatoid arthritis. Arthritis Rheum 14: 231–238Google Scholar
  18. 18.
    Erhardt CC, Mumford P, Maini RN (1979) The association of cryoglobulinaemia with nodules, vasculitis and fibrosing alveolitis in rheumatoid arthritis and their relationship to serum C1q binding activity and rheudmatoid factor. Clin Exp Immunol 38: 405–413PubMedGoogle Scholar
  19. 19.
    Naama JK, Mitchell WS, Zoma A, Veitch J, Whaley K (1983) Complement mediated inhibition of immune precipitation in patients with immune complex diseases. Clin Exp Immunol 51: 292–298PubMedGoogle Scholar
  20. 20.
    Mitchell WS, Veitch J, Hunter J, Zoma A, Capell H, Whaley K (1986) An inhibitor of complement mediated prevention of immune precipitation in rheumatoid arthritis — relationship to disease activity and systemic manifestations. Rheumatol Int 6: 209–213CrossRefPubMedGoogle Scholar
  21. 21.
    Ahmed AEE, Whaley K (1988) Purification of a plasma protein that inhibits complement mediated prevention of immune precipitation. Immunology 64: 45–50PubMedGoogle Scholar
  22. 22.
    Rosano CL, Braun CB, Hechemy KE, Parhame N, Satoh PA, Hurwitz C (1988) Inhibition of C1q functions by RHP, a protein elevated in sera from patients with rheumatoid arthritis. Complement 5: 57–64PubMedGoogle Scholar
  23. 23.
    Kerr MA, Wilton E, Naama JK, Whaley K (1986) Circulating immune complexes associated with decreased complement mediated inhibition of immune precipitation in patients with bacterial endocarditis. Clin Exp Immunol 63: 359–366PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1990

Authors and Affiliations

  • M. M. O'Sullivan
    • 1
  • N. Amos
    • 1
  • A. Bedwell
    • 1
  • B. D. Williams
    • 1
  1. 1.Rheumatology DepartmentUniversity Hospital of WalesCardiffUK

Personalised recommendations